Your English writing platform
Discover LudwigExact(13)
The drug, administered through injections, was meant to target plaque buildup around neurons, a heavily studied sign of the disease, though not necessarily a main cause.
Target plaque photography was performed for illustrative purposes at only two investigator centres.
For TPSS and TPA evaluation, a single target plaque was selected at baseline.
During angioscopic observations, an assistant adjusted the light power to maintain a constant brightness level on the target plaque.
Secondary endpoints (target plaque area and Itch Severity Item) improved similarly for tofacitinib ointment vs. corresponding vehicle.
For TPA, the target plaque perimeter was traced at each visit and its size quantified by computerized image analysis (planimetry).
Similar(47)
In all the secondary endpoints studied (scalp lesion, lesion of target plaque-erythema, infiltration, and scaling) a significant improvement was observed in the group treated with Oravex® compared with the control group after 8 weeks of treatment.
Plaques that were intertriginous or on the hands, feet, neck, face, elbows, knees, below the knees or on the scalp were not eligible as target plaques or included in the treatment area.
In addition to targeting plaque inflammation with 18FDG, a number of specific biomarkers, such as P-selectin, VCAM, metalloproteinases, and integrins have been investigated for imaging in mouse models and in human endarterectomy specimens [1]-[7].
As a result, interventions targeting plaque progression have been tested to elucidate the effect of CXCL10 inhibition in vivo.
However, as reviewed recently [ 67], therapeutic approaches targeting plaque and approaches targeting soluble Aβ have both now been tested in humans, with equally negative outcomes.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com